| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 334 / 669 | 50th | Q2 |
| Biochemistry, Genetics and Molecular Biology (all) | 175 / 223 | 21st | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biomeditsinskaya Khimiya
Biomeditsinskaya Khimiya is Scopus-indexed (Q2, CiteScore 1.3). Published by Russian Academy of Medical Sciences.
Checked against the index lists dated .
ISSN 2310-6905Verify ISSN ↗2310-6972Verify ISSN ↗
Publisher: Russian Academy of Medical Sciences
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Biomeditsinskaya Khimiya indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2003–present, best quartile Q2, CiteScore 1.3.
What quartile is Biomeditsinskaya Khimiya in Scopus?
Biomeditsinskaya Khimiya is Q2 in Medicine (all) (rank 334 of 669) and Q4 in Biochemistry, Genetics and Molecular Biology (all) (rank 175 of 223), by CiteScore 2025.
What is the impact factor of Biomeditsinskaya Khimiya?
Biomeditsinskaya Khimiya is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.3, quartile Q2, 50th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.218, quartile Q4, with an H-index of 20.
Who publishes Biomeditsinskaya Khimiya and what is its ISSN?
Biomeditsinskaya Khimiya is published by Russian Academy of Medical Sciences. Its print ISSN is 2310-6905 and its online ISSN is 2310-6972.
Is Biomeditsinskaya Khimiya in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Biomeditsinskaya Khimiya open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Biomeditsinskaya Khimiya? — open metrics via OpenAlex
Biomeditsinskaya Khimiya has an h-index of 23 and a 2-year mean of 1.19 citations per paper (OpenAlex). Its Scopus CiteScore is 1.3, quartile Q2. On 2-year citations it ranks #228 of 646 Scopus journals in Medicine (all).
Biomeditsinskaya Khimiya published 39 papers in 2025; its busiest recent year was 2017 with 76. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Biomeditsinskaya Khimiya? — latest 100 articles, 2024–2026
In its latest 100 research articles (2024–2026), authors are most often from Russia (87%), Belarus (3.5%) and Iraq (2.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Biomeditsinskaya Khimiya? — indicators, not proof of misconduct
Scopus status: Active. 2 retracted papers are recorded (1.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 2 · 1.9 per 1,000 papers
- Problematic Paper Screener flags None flagged
- Author concentration87% of recent authorship from Russia
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.